-
L-Threonine: From Nutrient Flux to Assay Confidence
2026-08-25
A translational guide to using L-Threonine as a controlled metabolic input while applying mechanistically resolved, metal-free nanozyme assays to improve experimental interpretation and workflow confidence.
-
How Near-Death Stress Creates Prometastatic Tumor States
2026-08-24
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving impending death can become stable prometastatic cells called PAMEs. Their study links ER stress, PERK-CHOP signaling, GLI and NANOG-dependent reprogramming, and a cytokine-mediated interaction with neighboring PIM cells to the origin of metastatic behavior.
-
HEY2, Mitochondrial Respiration, and Heart Failure
2026-08-24
This study identifies HEY2 as an evolutionarily conserved transcriptional brake on cardiac mitochondrial oxidative respiration. Through complementary zebrafish, mouse, human cardiomyocyte, and genome-wide analyses, it connects HEY2/HDAC1 repression of PPARGC1A, ESRRA, and CPT1-associated programs with reactive oxygen species, cardiomyocyte loss, and heart failure.
-
FDA-Approved Drugs Against MERS-CoV: Study Analysis
2026-08-23
De Wilde and colleagues screened 348 FDA-approved compounds and identified chloroquine, chlorpromazine, loperamide, and lopinavir as low-micromolar inhibitors of MERS-CoV replication in cell culture. The study illustrates how drug repurposing can rapidly generate antiviral leads, while also showing why cell-based activity must be separated from clinical efficacy.
-
VX-702: Practical p38α MAPK Workflows
2026-08-22
VX-702 combines potent, selective p38α MAPK inhibition with workflow flexibility for cytokine, arthritis, platelet, and cardiac injury studies. This guide translates its ATP-competitive profile and emerging activation-loop biology into practical assay design, controls, and troubleshooting decisions.
-
Toremifene Citrate: From ER Biology to Translation
2026-08-21
A translational framework for using Toremifene Citrate to connect estrogen receptor biology, assay design, comparative evidence, and breast cancer research strategy.
-
SPI1/miR-616-5p Axis in NSCLC Metastasis
2026-08-20
The reference study identifies an SPI1/miR-616-5p regulatory axis that promotes non-small cell lung cancer invasion and migration and shows that sulforaphane can disrupt this pathway. Its main translational innovation is an hyaluronic acid- and folic acid-modified mesoporous silica nanoparticle system that improves sulforaphane stability, uptake, tumor targeting, and anti-metastatic activity in NSCLC models.
-
GSH and GSSG Assay Kit for Redox Analysis
2026-08-20
The GSH and GSSG Assay Kit supports reduced glutathione detection and separate GSSG measurement in biological samples. Its DTNB-based spectrophotometric workflow reports a 0.5 μM detection limit under the stated kit configuration and provides a practical endpoint for oxidative stress research and redox state analysis.
-
Safe DNA Gel Stain for Phage DNA Workflows
2026-08-19
Safe DNA Gel Stain supports sensitive DNA and RNA gel analysis while enabling blue-light visualization that can help limit UV exposure and protect clonable DNA. Its flexible in-gel or post-electrophoresis formats are useful for plasmid checks, phage-genome quality control, and nucleic acid recovery workflows.
-
HyperScript RT SuperMix for qPCR in Innate Immunity
2026-08-19
HyperScript RT SuperMix for qPCR supports reliable cDNA synthesis for qPCR studies of cGAS-STING and RIG-I/MDA5-MAVS signaling. This article presents an assay-design framework that separates RNA quality, pathway activation, and biological interpretation in cancer immunology.
-
Nebivolol hydrochloride: β1 Signaling Workflows
2026-08-18
Build cleaner cardiovascular pharmacology experiments with a selective β1-adrenoceptor antagonist, while using a drug-sensitized yeast assay as an orthogonal check for TOR-related effects. This guide connects receptor-focused workflows, practical DMSO handling, and troubleshooting with evidence from a recent mTOR inhibitor discovery study.
-
Prostaglandin E2 in Pancreatic Organoid Workflows
2026-08-18
Prostaglandin E2 adds a tunable receptor-level perturbation to pancreatic ductal organoid studies without replacing the reference study’s high-efficiency small-molecule cocktail. This guide connects PGE2 handling, dose-response design, organoid phenotyping, and troubleshooting for inflammation research, epithelial injury studies, and screening workflows.
-
Safe DNA Gel Stain: A Safer Imaging Strategy
2026-08-17
Safe DNA Gel Stain supports sensitive DNA and RNA gel staining while helping laboratories replace UV-dependent workflows with blue-light visualization. This article presents an assay-centered framework for choosing stains, imaging conditions, and controls without confusing gel-based quality control with diagnostic detection.
-
Propranolol Rewires Burn Injury Metabolism
2026-08-17
This phase II randomized controlled trial links propranolol treatment after severe burn injury to coordinated changes in adipose-tissue metabolomics, lipidomics, hormone-sensitive lipase activity, and endoplasmic reticulum stress. The findings provide a mechanistic framework for understanding how β-adrenergic blockade may reduce postburn hypermetabolism and shift inflammatory lipid signaling.
-
β-Elemene Inhibits Adipogenesis via AMPK in 3T3-L1 Cells
2026-08-16
The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 preadipocytes and links this effect to restoration of AMPK pathway activity. Its value is primarily mechanistic: the work connects lipid accumulation, insulin resistance-related glucose handling, and AMPK signaling in a defined cellular model while also clarifying the limits of extrapolating these findings to obesity treatment.